Valneva SE

PINK:INRLF USA Biotechnology
Market Cap
$501.76 Million
Market Cap Rank
#11009 Global
#4994 in USA
Share Price
$2.92
Change (1 day)
-15.36%
52-Week Range
$2.92 - $3.50
All Time High
$33.30
About

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile t… Read more

Valneva SE (INRLF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.116x

Based on the latest financial reports, Valneva SE (INRLF) has a cash flow conversion efficiency ratio of -0.116x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.44 Million) by net assets ($150.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Valneva SE - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Valneva SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Valneva SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Valneva SE ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Valneva SE (2005–2024)

The table below shows the annual cash flow conversion efficiency of Valneva SE from 2005 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $181.25 Million $-67.22 Million -0.371x +76.54%
2023-12-31 $128.25 Million $-202.74 Million -1.581x -41.63%
2022-12-31 $219.80 Million $-245.34 Million -1.116x -347.60%
2021-12-31 $170.58 Million $76.90 Million 0.451x -74.66%
2020-12-31 $77.42 Million $137.74 Million 1.779x +4248.79%
2019-12-31 $135.15 Million $5.53 Million 0.041x -64.08%
2018-12-31 $143.19 Million $16.31 Million 0.114x -17.74%
2017-12-31 $92.67 Million $12.83 Million 0.138x +112.93%
2016-12-31 $100.05 Million $6.50 Million 0.065x +138.56%
2015-12-31 $144.34 Million $-24.33 Million -0.169x -40.39%
2014-12-31 $124.44 Million $-14.94 Million -0.120x +17.21%
2013-12-31 $144.11 Million $-20.90 Million -0.145x +71.26%
2012-12-31 $26.19 Million $-13.22 Million -0.505x -135.82%
2011-12-31 $40.45 Million $-8.66 Million -0.214x -200.52%
2010-12-31 $44.29 Million $-3.15 Million -0.071x -270.86%
2009-12-31 $22.53 Million $939.00K 0.042x +162.04%
2008-12-31 $27.42 Million $-1.84 Million -0.067x +45.33%
2007-12-31 $29.01 Million $-3.56 Million -0.123x +79.07%
2006-12-31 $4.66 Million $-2.73 Million -0.587x -511.87%
2005-12-31 $4.78 Million $681.00K 0.143x --